Clinical Trials Logo

Clinical Trial Summary

This study aimed to evaluate the safety and efficacy of unrelated umbilical cord blood microtransplantation in the treatment of AML patients by observing the factors related to the efficacy and adverse reactions.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06105658
Study type Interventional
Source Anhui Provincial Hospital
Contact Xiaoyu Zhu, MD
Phone 15255456091
Email xiaoyuz@ustc.edu.cn
Status Recruiting
Phase Phase 2
Start date October 2023
Completion date February 1, 2026

See also
  Status Clinical Trial Phase
Recruiting NCT02244658 - Recombinant Human Thrombopoietin (rhTPO) in Management of Chemotherapy-induced Thrombocytopenia in Acute Myelocytic Leukemia Phase 3
Completed NCT01462578 - Treatment of Patients With Myelodysplastic Syndrome or Acute Myelocytic Leukemia With an Impending Hematological Relapse With Azacitidine (Vidaza) Phase 2
Completed NCT01188798 - Methotrexate or Pentostatin for Graft-versus-host Disease Prophylaxis in Risk-adapted Allogeneic Bone Marrow Transplantation for Hematologic Malignancies Phase 3
Completed NCT00854646 - Phase I Study of ON 01910.Na in Refractory Leukemia or Myelodysplastic Syndrome (MDS) Phase 1
Completed NCT00152139 - Stem Cell Transplantation for Patients With Hematologic Malignancies Phase 3
Completed NCT00061581 - Experimental Bone Marrow Transplant Protocol Phase 2
Completed NCT01167166 - Safety and Efficacy of 72-hour and 120-hour Infusion of Rigosertib in Acute Myeloid Leukemia (AML) and Acute Lymphoid Leukemia (ALL) Phase 1/Phase 2
Completed NCT01474681 - Safety and Tolerability of HSC835 in Patients With Hematological Malignancies Phase 1/Phase 2
Terminated NCT02255162 - Lenalidomide in Combination With Microtransplantation as Post-remission Therapy in AML Phase 1
Active, not recruiting NCT01809392 - Decitabine Augments for Post Allogeneic Stem Cell Transplantation in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome Phase 2/Phase 3
Recruiting NCT00155844 - Studies on the Significance of CXCR4-CXCL12 on Leukemic Cells Passing Through"Marrow-Blood Barrier" N/A
Recruiting NCT03796390 - Study Evaluating Safety and Efficacy of CAR-T Cells Targeting CD123 in Patients With Acute Myelocytic Leukemia Phase 1
Terminated NCT01621477 - T-Cell Replete Haploidentical Donor Hematopoietic Stem Cell Plus Natural Killer (NK) Cell Transplantation in Patients With Hematologic Malignancies Relapsed or Refractory Despite Previous Allogeneic Transplant Phase 2
Completed NCT00559091 - A Study of Ribavirin to Treat M4 and M5 Acute Myelocytic Leukemia Phase 2
Completed NCT00015587 - Molecular Epidemiology of Childhood Leukemia (Aka The California Childhood Leukemia Study) N/A